Captrust Financial Advisors Iterum Therapeutics PLC Transaction History
Captrust Financial Advisors
- $46.7 Billion
- Q3 2025
A detailed history of Captrust Financial Advisors transactions in Iterum Therapeutics PLC stock. As of the latest transaction made, Captrust Financial Advisors holds 111,600 shares of ITRM stock, worth $52,452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,600
Previous 11,500
870.43%
Holding current value
$52,452
Previous $11,000
572.73%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ITRM
# of Institutions
4Shares Held
194KCall Options Held
0Put Options Held
0About Iterum Therapeutics plc
- Ticker ITRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,233,400
- Market Cap $5.75M
- Description
- Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...